SMOC1 and Alzheimer disease: Notably, in vivo measurements of fibrillary amyloid plaques in the brain of AD patients using the PET ligand florbetapir (AV45) was most strongly associated with SMOC1, further supporting its role as an important surrogate marker of underlying Aβ pathology in brain [8].